Cannabis Bioscience International Holdings, Inc. (CBIH) — SEC Financial Statements & Analysis

Cannabis Bioscience International Holdings, Inc. (CBIH) is a services-commercial physical & biological research company, incorporated in CO. Cannabis Bioscience International Holdings, Inc. trades on OTC as: CBIH. Cannabis Bioscience International Holdings, Inc. (CBIH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-02-28, filed with the SEC on 2026-04-16. Based on that filing, Cannabis Bioscience International Holdings, Inc. carries a market cap of $4.65M, a P/E ratio of -7.82x, a P/B ratio of -3.17x, a P/S ratio of 23.50x, an enterprise value of $4.67M, and an EV/EBITDA multiple of -10.18x. On profitability, it posts a gross margin of 82.80%, an operating margin of -231.69%, a net margin of -300.60%, a Return on Equity (ROE) of 44.18%, and a Return on Assets (ROA) of -7240.61%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -47.78% year-over-year, net income growth of -24.18% year-over-year, and EPS growth of -30.05% year-over-year. On the balance sheet, it maintains a current ratio of 0.00x, a quick ratio of 0.00x, working capital of $-1.22M, a debt-to-equity ratio of -1.00x, a debt ratio of 951.21, an interest coverage ratio of -2.91x, free cash flow of $-268.11K (TTM), and net debt of $14.50K. Figures sourced from SEC EDGAR.

Market Cap

$4.65M

P/E TTM

-7.82x

EPS TTM

$-0.00

P/B TTM

-3.17x

ROE TTM

44.18%

ROA TTM

-7240.61%

Debt To Equity

-1.00x

Free Cash Flow TTM

$-268.11K

Net Revenue TTM Growth 1Y

-47.78%

Data as of 2026-02-28 · Source: SEC EDGAR